TABLE 3.

CpGs methylation across the patients with Hepatocellular carcinoma based on SMART database.

CGIposition	UCSC_RefGene_Group	Probe	Overall survival
			Hazard ratio (95% CI) cutoff-high 50%, -low 50%	p-value
Open_Sea	Body	cg1549455g	0.7 (0.5–0.99)	0.0423
	Body	cg03451779	0.89 (0.63–1.25)	n.s
	Body	cg24878005	0.92 (0.64–1.27)	n.s
	Body	cg11182199	0.91 (0.64–1.27)	n.s
	Body	cg11878867	0.86 (0.61–1.21)	n.s
	Body	cg24112628	1.47 (1.05–2.07)	0.0273
N_Shore	Body	cg11708358	0.71 (0.51–1)	0.0487
	Body	cg13569583	0.89 (0.63–1.25)	n.s
Island	Body	cg24761195	1.07 (0.76–1.51)	n.s
	1stExon	cg03401324	1.02 (0.72–1.43)	n.s
	1stExon	cg07807409	1.8 (1.28–2.53)	0.0008
	TSS200	cg05971912	1.2 (0.86–1.69)	n.s
	TSS200	cg25083496	1.47 (1.04–2.07)	0.0273
	TSS200	cg07310318	0.81 (0.58–1.14)	n.s
	TSS200	cg20685554	1.06 (0.76–1.49)	n.s
S_Shore	TSS1500	cg20206129	0.93 (0.66–1.3)	n.s
	TSS1500	cg12232274	0.7 (0.5–0.99)	0.0415

Note: UCSC_RefGene_Group (gene region, based on UCSC, annotations).